USPTO Clarifies IP Disclosure Duties Amid Drug Pricing Push
The U.S. Patent and Trademark Office reinforced disclosure and inquiry duties for patent applications and challenges Friday as the agency works toward strengthening the drug patent system and limiting abuse....To view the full article, register now.
Already a subscriber? Click here to view full article